Ozempic's PR battle

By Memo
| October 05, 2023

We analyzed readership data around Ozempic to understand the conversation, uncover trends, and identify PR learnings.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...